- Home
- SPNS vs IRON Comparison
SPNS vs IRON Comparison
Compare SPNS & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPNS
- IRON
- Stock Information
- Founded
- SPNS 1982
- IRON 2017
- Country
- SPNS Israel
- IRON United States
- Employees
- SPNS N/A
- IRON N/A
- Industry
- SPNS Computer Software: Prepackaged Software
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- SPNS Technology
- IRON Health Care
- Exchange
- SPNS Nasdaq
- IRON Nasdaq
- Market Cap
- SPNS 1.6B
- IRON 1.8B
- IPO Year
- SPNS 1992
- IRON N/A
- Fundamental
- Price
- SPNS $30.09
- IRON $54.75
- Analyst Decision
- SPNS Buy
- IRON Strong Buy
- Analyst Count
- SPNS 4
- IRON 11
- Target Price
- SPNS $34.25
- IRON $92.64
- AVG Volume (30 Days)
- SPNS 158.6K
- IRON 423.3K
- Earning Date
- SPNS 07-31-2025
- IRON 08-07-2025
- Dividend Yield
- SPNS 1.99%
- IRON N/A
- EPS Growth
- SPNS 11.11
- IRON N/A
- EPS
- SPNS 1.30
- IRON N/A
- Revenue
- SPNS $544,235,000.00
- IRON N/A
- Revenue This Year
- SPNS $8.30
- IRON N/A
- Revenue Next Year
- SPNS $7.42
- IRON N/A
- P/E Ratio
- SPNS $23.15
- IRON N/A
- Revenue Growth
- SPNS 3.84
- IRON N/A
- 52 Week Low
- SPNS $23.69
- IRON $30.82
- 52 Week High
- SPNS $41.22
- IRON $68.73
- Technical
- Relative Strength Index (RSI)
- SPNS 64.37
- IRON 59.95
- Support Level
- SPNS $28.44
- IRON $51.01
- Resistance Level
- SPNS $29.56
- IRON $55.52
- Average True Range (ATR)
- SPNS 0.51
- IRON 2.43
- MACD
- SPNS 0.09
- IRON -0.02
- Stochastic Oscillator
- SPNS 94.98
- IRON 88.42
About SPNS Sapiens International Corporation N.V. (Cayman Islands)
Sapiens International Corp NV is a provider of software solutions for the insurance industry, with an emerging focus on the financial services sector. The company offers software, solutions, and professional services for property & casualty (P&C); reinsurance; life, pension & annuity (L&A); workers' compensation (WC); medical professional liability (MPL); financial & compliance (F&C); and decision modeling for both insurance and financial markets. The group also provides services for project delivery and implementation services, for its Software Solutions portfolio. Geographically, it operates in the region of North America, Rest of the World, and Europe. It generates revenue from Europe.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.